参考文献/References:
[1] Deng X,Wang P,Yuan H.Epidemiology,risk factors across the spectrum of age-related metabolic diseases[J].J Trace Elem Med Biol,2020,61:126497.DOI:10.1016/jtemb.2020.126497.
[2] Endo M. The roles of ANGPTL families in cancer progression[J].J UOEH,2019,41(3):317-325.DOI:10.7888/juoeh.41.317.
[3] Oike Y,Akao M,Yasunaga K,et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance[J].Nat Med,2005,11(4):400-408.DOI:10.1038/nm1214.
[4] Qaddoumi MG,Alanbaei M,Hammad MM,et al. Investigating the role of myeloperoxidase and angiopoietin-like protein 6 in obesity and diabetes[J].Sci Rep,2020,10(1):6170.DOI:10.1038/s41598-020-63149-7.
[5] Sharma V,Pangtey GS,Gupta R,et al. Correlation of long-term glycemic control as measured by glycated hemoglobin with serum angiopoietin-like 6 protein levels in type 2 diabetes mellitus patients[J].Indian J Pharmacol,2017,49(3):250-253.DOI:10.4103/ijp.IJP_261_16.
[6] Kim JH. Letter:increased serum angiopoietin-like 6 ahead of metabolic syndrome in a prospective cohort study(Diabetes Metab J 2019; 43:521-9)[J].Diabetes Metab J,2019,43(5):727-728.DOI:10.4093/dmj.2019.0172.
[7] Santulli G. Angiopoietin-like proteins:a comprehensive look[J].Front Endocrinol(Lausanne),2014,5:4.DOI:10.3389/fendo.2014.00004.
[8] Legry V,Goumidi L,Huyvaert M,et al. Association between angiopoietin-like 6(ANGPTL6)gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study[J].Diabetes Metab,2009,35(4):287-292.DOI:10.1016/j.diabet.2008.12.005.
[9] Oike Y,Yasunaga K,Ito Y,et al. Angiopoietin-related growth factor(AGF)promotes epidermal proliferation,remodeling,and regeneration[J].Proc Natl Acad Sci U S A,2003,100(16):9494-9499.DOI:10.1073/pnas.1531901100.
[10] Hato T,Tabata M,Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism[J].Trends Cardiovasc Med,2008,18(1):6-14.DOI:10.1016/j.tcm.2007.10.003.
[11] Kadomatsu T,Tabata M,Oike Y. Angiopoietin-like proteins:emerging targets for treatment of obesity and related metabolic diseases[J].FEBS J,2011,278(4):559-564.DOI:10.1111/j.1742-4658.2010.07979.x.
[12] Kang SG,Yi HS,Choi MJ,et al. ANGPTL6 expression is coupled with mitochondrial OXPHOS function to regulate adipose FGF21[J].J Endocrinol,2017,233(1):105-118.DOI:10.1530/JOE-16-0549.
[13] Cinkajzlova A,Lacinova Z,Klouckova J,et al. Angiopoietin-like protein 6 in patients with obesity,type 2 diabetes mellitus,and anorexia nervosa:the influence of very low-calorie diet,bariatric surgery,and partial realimentation[J].Endocr Res,2017,42(1):22-30.DOI:10.3109/07435800.2016.1169544.
[14] Namkung J,Koh SB,Kong ID,et al. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome[J].Metabolism,2011,60(4):564-568.DOI:10.1016/j.metabol.2010.05.013.
[15] Gonzalez-Cantero J,Martin-Rodriguez JL,Gonzalez-Cantero A,et al. Insulin resistance in lean and overweight non-diabetic Caucasian adults:study of its relationship with liver triglyceride content,waist circumference and BMI[J].PLoS One,2018,13(2):e0192663.DOI:10.1371/journal.pone.0192663.
[16] Al-Sulaiti H,Diboun I,Banu S,et al. Triglyceride profiling in adipose tissues from obese insulin sensitive,insulin resistant and type 2 diabetes mellitus individuals[J].J Transl Med,2018,16(1):175.DOI:10.1186/s12967-018-1548-x.
[17] Fan KC,Wu HT,Wei JN,et al. Serum angiopoietin-like protein 6,risk of type 2 diabetes,and response to hyperglycemia:a prospective cohort study[J].J Clin Endocrinol Metab,2020,105(5):dgaa103.DOI:10.1210/clinem/dgaa103.
[18] Ebert T,Kralisch S,Loessner U,et al. Relationship between serum levels of angiopoietin-related growth factor and metabolic risk factors[J].Horm Metab Res,2014,46(10):685-690.DOI:10.1055/s-0034-1382078.
[19] Abdullah B,Deveci K,Atilgan R,et al. Serum angiopoietin-related growth factor(AGF)levels are elevated in gestational diabetes mellitus and associated with insulin resistance[J].Ginekol Pol,2012,83(10):749-753.
[20] Boztosun A,Deveci K,Klçl F,et al. Serum levels of angiopoietin-related growth factor(AGF)are increased in polycystic ovary syndrome[J].J Investig Med,2012,60(5):813-817.DOI:10.2310/JIM.0b013e31824e9900.
[21] Elci E,Kaya C,Cim N,et al. Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries[J].Gynecol Endocrinol,2017,33(1):43-47.DOI:10.1080/09513590.2016.1203893.
相似文献/References:
[1]刘丹丹,王丽,史兴晔,等.脂肪酸受体GPR120影响胰岛素受体底物-1的表达[J].国际内分泌代谢杂志,2014,(06):371.[doi:10.3760/cma.j.issn.1673-4157.2014.06.003]
Liu Dandan*,Wang Li,Shi Xingye,et al.Regulation of fatty acid receptor GPR120 on the expression of insulin receptor substrate-1[J].International Journal of Endocrinology and Metabolism,2014,(03):371.[doi:10.3760/cma.j.issn.1673-4157.2014.06.003]
[2]李新萍,张萍,李晓玉.螺内酯对特发性醛固酮增多症患者胰岛β细胞功能的影响[J].国际内分泌代谢杂志,2014,(06):379.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
Li Xinping,Zhang Ping,Li Xiaoyu..Effects of spironolactone on islet β cell function in patients with idiopathic hyperaldosteronism[J].International Journal of Endocrinology and Metabolism,2014,(03):379.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
[3]胡雅琴,包玉倩.维生素D对非酒精性脂肪性肝病的保护作用[J].国际内分泌代谢杂志,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
Hu Yaqin,Bao Yuqian..Protective effect of vitamin D on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(03):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
[4]张琳,王晓琳,李小英.雄激素与糖脂代谢的关系[J].国际内分泌代谢杂志,2014,(05):351.[doi:10.3760/cma.j.issn.1673-4157.2014.05.018]
Zhang Lin,Wang Xiaolin,Li Xiaoying..The relationship between testosterone and glycolipid,metabolism[J].International Journal of Endocrinology and Metabolism,2014,(03):351.[doi:10.3760/cma.j.issn.1673-4157.2014.05.018]
[5]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(03):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[6]王锐 陆强 王术艺 朱东林 蒋韬 马宁 刘悦 李燕莉
贾晓娇 姚立新.血清25羟维生素D及vaspin水平与妊娠糖尿病关系的研究[J].国际内分泌代谢杂志,2015,(05):306.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.005]
Wang Rui,Lu Qiang,Wang Shuyi,et al.Relationship between serum 25-hydroxyvitamin D, vaspin and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):306.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.005]
[7]黄祺 程海燕 卜瑞芳.1-磷酸鞘胺醇与胰岛素抵抗[J].国际内分泌代谢杂志,2015,(05):348.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.015]
Huang Qi,Cheng Haiyan,Bu Ruifang..Sphingosine-1-phosphate and insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(03):348.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.015]
[8]李少卿 王坚.2型糖尿病患者血25-羟维生素D3缺乏
对胰岛素抵抗及骨量的影响[J].国际内分泌代谢杂志,2015,(06):384.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.006]
Li Shaoqing*,Wang Jian..The influence of 25-hydroxyl vitamin D3 deficiency on insulin resistance and bone mass in patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):384.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.006]
[9]李晶,董荣娜,于德民.有氧运动对胰岛素抵抗小鼠visfatin
表达的影响[J].国际内分泌代谢杂志,2016,36(01):10.[doi:10.3760/cma.j.issn.1673-4157.2016.01.003]
Li Jing,Dong Rongna,Yu Demin..Effects of aerobic exercise on the expression of visfatin in mice with insulin resistance[J].International Journal of Endocrinology and Metabolism,2016,36(03):10.[doi:10.3760/cma.j.issn.1673-4157.2016.01.003]
[10]张琳,费雯婕,宋光耀.网膜素与代谢综合征[J].国际内分泌代谢杂志,2016,36(01):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
Zhang Lin*,Fei Wenjie,Song Guangyao..Omentin and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(03):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]